XP Health is a company.
XP Health has raised $55.0M across 3 funding rounds.
Key people at XP Health.
XP Health has raised $55.0M in total across 3 funding rounds.
Key people at XP Health.
XP Health has raised $55.0M in total across 3 funding rounds.
XP Health's investors include Afore Capital, Bessemer Venture Partners, Comal Ventures, DGF Investimentos, Framework Ventures, ManchesterStory Group, QED Investors, SoftBank Investment Advisers, Valor Capital Group, Oded Hermoni, 9Yards Capital, Kevin Hartz.
XP Health is a digital-first vision care platform that reimagines employee vision benefits by offering online prescription renewals, AI-powered glasses recommendations, virtual try-ons, and access to over 100,000 providers, making high-quality vision care seamless, affordable, and accessible.[1][2][3] It primarily serves large employers, health plans, and their workforces—over 500,000 members across 3,500 business customers including Fortune 500 companies like DocuSign and partners like Guardian Life—solving the problem of outdated, confusing, expensive vision programs that lead to low usage and poor ROI through total price transparency, no claims processing, and up to 70% cost reductions.[2][3][4][6] The company has demonstrated strong growth momentum, expanding from 10,000 members three years ago to over 400,000 today (recently surpassing 500,000), securing $22M in funding from top healthcare VCs, earning Inc. 5000's Fastest-Growing Companies recognition, TIME's Top HealthTech list in 2025, and B Corp Certification for its social and environmental impact.[1][2][4]
Founded in 2018 and headquartered in San Carlos, California, XP Health emerged from the personal frustrations of its co-founder and CEO Antonio Moraes with confusing, expensive vision programs, inspiring him to leverage technology for change after a pivotal life moment at age 17 that shaped his purpose as a social entrepreneur and impact investor.[1][2][5] Starting as a small, scrappy team, the company quickly gained traction by launching a groundbreaking platform that boosted member satisfaction by 70 NPS points and cut costs by 70%, attracting early enterprise partners and growing to 30 customers initially, then exploding to over 3,000 including Navistar, Chegg, and Sequoia Consulting.[1][2] Key milestones include raising $22M in funding and achieving B Corp status in late 2025, reflecting its evolution from a startup challenger to a leader in transparent, equitable vision care.[1][4][5]
XP Health rides the wave of digital health transformation and AI personalization in employee benefits, targeting the stagnant $40B+ U.S. vision care market dominated by legacy providers with low usage due to friction—timing amplified by post-pandemic demand for telehealth, remote work eye strain, and employer focus on ROI-driven perks.[2][3][7] Favorable market forces include rising healthcare costs pushing transparency, AI advancements enabling scalable personalization, and B Corp trends signaling investor/consumer preference for purpose-driven tech, positioning XP Health to influence the ecosystem by partnering with brokers like Health Benefit Alliance and setting benchmarks for equitable access.[4][5][6] Its growth to 3,500 customers and recognitions like TIME's HealthTech list underscore its role in disrupting traditional eyewear retail and insurance models, fostering higher adoption of modern benefits.[2][4]
XP Health is poised for continued hypergrowth by doubling down on AI enhancements for eye health, expanding its provider network, and scaling B Corp initiatives like community glasses programs amid trends in personalized telehealth and sustainable healthtech.[2][4][5] Evolving employer demands for measurable ROI and hybrid work will propel it toward 1 billion people served, potentially through more white-label partnerships and international case studies, solidifying its lead in democratizing vision care.[1][6][8] As a B Corp pioneer in a legacy industry, its influence will grow by proving profitable impact is scalable, tying back to its origins in breaking barriers for accessible, high-quality vision.
XP Health has raised $55.0M across 3 funding rounds. Most recently, it raised $33.0M Series B in September 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2024 | $33.0M Series B | Afore Capital, Bessemer Venture Partners, Comal Ventures, DGF Investimentos, Framework Ventures, ManchesterStory Group, QED Investors, SoftBank Investment Advisers, Valor Capital Group, Oded Hermoni | |
| Sep 1, 2022 | $17.0M Series A | 9Yards Capital, Kevin Hartz, Accel, Base Partners, Bessemer Venture Partners, Comal Ventures, Curie.Bio, Day One Ventures, DGF Investimentos, Framework Ventures, Index Ventures, ManchesterStory Group, Prototype Capital, QED Investors, Sequoia Capital, SoftBank Investment Advisers, Two Sigma Ventures, Valor Capital Group, Aaron Levie, Julia Hartz, Oded Hermoni, Sahin Boydas | |
| Jan 1, 2021 | $5.0M Seed | Bessemer Venture Partners, Comal Ventures, ManchesterStory Group, QED Investors, SoftBank Investment Advisers, Valor Capital Group, Oded Hermoni, Ravi Grover |
